SPIRIVA® Respimat® (tiotropium) for COPD
COPD
What is COPD?
Chronic obstructive pulmonary disease (COPD) is a group of long-term conditions caused by damage to the lungs, which can make it difficult to breathe.1,2
When patients have COPD, the air sacs inside their lungs may collapse when breathing in and the airways may become inflamed and narrowed.1,2
Symptoms
Patients with COPD may experience some of the following symptoms, which can make it harder to carry out everyday tasks:2
How is COPD treated?
Inhaled medicines are usually used to treat COPD to help patients manage their symptoms.2,3
What is SPIRIVA Respimat (tiotropium)?
SPIRIVA Respimat (tiotropium) is used to help people who have chronic obstructive pulmonary disease (COPD) or severe asthma to breath more easily. It contains the active ingredient tiotropium which is a bronchodilator (long-acting muscarinic antagonist).3
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. The most common side effect (may affect up to 1 in 10 people) which may be experienced when taking SPIRIVA Respimat (tiotropium) for COPD is dry mouth.3
In addition, in common with all inhaled medicines, some patients may experience an unexpected tightness of the chest, coughing, wheezing or breathlessness immediately after inhalation (bronchospasm). If any of these occur, please consult your doctor immediately.3
Please refer to the patient information leaflet for further information about possible side effects.
Where can I find more information about SPIRIVA Respimat (tiotropium)?
Patient Information Leaflet
The Patient Information Leaflet is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using this medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Patient Information Leaflet
Summary of Product Characteristics
The Summary of Product Characteristics (SmPC) tells healthcare professionals, such as doctors, pharmacists and nurses, how to prescribe and use this medicine correctly. The information in the Patient Information Leaflet and Summary of Product Characteristics are not intended to replace the opinion of a healthcare professional.
Summary of Product Characteristics
References
-
1.
Asthma + Lung UK. What is COPD? Available from: https://www.asthmaandlung.org.uk/conditions/copd-chronic-obstructive-pulmonary-disease/what-copd (Accessed October 2024).
-
2.
NHS Choices. Chronic obstructive pulmonary disease (COPD). Available from: https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/ (Accessed October 2024).
-
3.
SPIRIVA Respimat Patient Information Leaflet.
NP-GB-103750 | November 2024
